The phrase "added incremental value" is correct and usable in written English.
It can be used in contexts where you want to describe the additional benefits or improvements that something brings to a situation or project.
Example: "The new software features added incremental value to our existing system, enhancing user experience and efficiency."
Alternatives: "additional value" or "enhanced value".
WMSCI at peak-dose dobutamine and LVEF at rest added incremental value to the clinical parameters in predicting all-cause mortality (67 to 93 [ P < 0.0001] and 76 [ P < 0.0001], respectively).
For instance, Folsom et al.[ 15] looked at various novel markers to predict coronary heart disease, and tested whether these markers added incremental value to a standard predictive model that included age, race, sex, total cholesterol, high density lipoprotein, blood pressure, antihypertensive medications, smoking status, and diabetes.
On the other hand, lateral e' was shown to correlate with functional capacity (r=0.50, p=0.001) 16 and mitral E/e' was significantly higher in patients with HCM versus control (p<0.0001); 12 however, neither parameter was independently predictive of oxygen consumption nor added incremental value.
Each additional device or service, which creates that positive feedback loop of locking a user further and further down its rabbit hole, has the opportunity of adding incremental value to the company.
TEE can add incremental value to TTE, but may still fail to detect life-threatening signs of PHV endocarditis.
Please clearly define that strain will add incremental value to current routine assessment with TDI in finding out individuals who may develop adverse myocardial fibrosis.
The second major clinical challenge lies in determining, through appropriate studies, whether the new omics findings add incremental value to current clinical practices or clinical decision making.
Thus, our aim was to further assess whether the UKCAT is likely to add incremental value over A level (predicted or actual) attainment in the selection process.
Microvascular assessments are most likely to add incremental value in patient management to the extent that results can be applied expeditiously at the bedside.
Myocardial blood flow (MBF) measurements add incremental value to the diagnosis and evaluation of coronary artery disease (CAD) compared with qualitative perfusion imaging techniques [ 1, 4, 5].
Serial measurements of the precursor peptides of the natriuretic and vasopressin systems (midregional proatrial natriuretic peptide (MR-proANP) and C-terminal provasopressin (copeptin), respectively) should add incremental value to risk stratification in ambulatory patients with HF.
